<bill session="115" type="s" number="2669" updated="2023-01-11T13:39:42Z">
  <state datetime="2018-04-16">REFERRED</state>
  <status>
    <introduced datetime="2018-04-16"/>
  </status>
  <introduced datetime="2018-04-16"/>
  <titles>
    <title type="display">Advancing Innovation in Alternative Pain and Addiction Therapies Act</title>
    <title type="official" as="introduced">A bill to provide for accelerated approval of pain and addiction therapies.</title>
    <title type="short" as="introduced">Advancing Innovation in Alternative Pain and Addiction Therapies Act</title>
  </titles>
  <sponsor bioguide_id="H000338"/>
  <cosponsors>
    <cosponsor bioguide_id="B001267" joined="2018-04-16"/>
    <cosponsor bioguide_id="D000607" joined="2018-04-16"/>
    <cosponsor bioguide_id="S001184" joined="2018-04-26"/>
    <cosponsor bioguide_id="Y000064" joined="2018-04-16"/>
  </cosponsors>
  <actions>
    <action datetime="2018-04-16">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2018-04-16" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2019-08-28T15:03:20Z" status="Introduced in Senate">Advancing Innovation in Alternative Pain and Addiction Therapies Act

This bill requires the Food and Drug Administration to issue guidance clarifying eligibility and&#160;criteria for the accelerated approval&#160;of non-opioid or nonaddictive drugs to treat pain or substance-use disorders.</summary>
</bill>
